Thursday, July 9, 2020
Home Science & Technology Scientists develop a Drug likely to benefit people with Alzheimer’s Disease

Scientists develop a Drug likely to benefit people with Alzheimer’s Disease

Washington, Jan 27, 2017: Scientists have developed a drug they hope will benefit people with Alzheimer’s disease, which afflicts an estimated 44 million people around the world. The new compound sweeps away abnormal protein clumps in the brain which are a hallmark of the neurodegenerative disorder.

In a study reported in the journal Science Translational Medicine, researchers describe how a synthetic drug, called antisense oligoneucleotide, reduced the production and in some cases cleared clumps of tau in the brain.

NewsGram brings to you current foreign news from all over the world.

Tau bundles are one of the hallmarks of the disease, along with beta amyloid deposits, another destructive protein.

By stopping the formation of tau, researchers at Washington University School of Medicine in St. Louis, Missouri, found they could extend the lives of mice that were bred to have collections of human tau in their brains.

Lead author Sara DeVos said scientists saw an improvement in their condition.

“So these mice die earlier than normal. So when we treat with our drug, the mice live longer and we can also prevent neurons from dying. So if we give this drug, the neurons will no longer die as a result of these tau bundles,” said DeVos

NewsGram brings to you top news around the world today.

The investigators also tested the compound in monkeys and saw positive results.

FILE – Patients with Alzheimer’s and dementia are seen during a therapy session. Alzheimer’s afflicts an estimated 44 million people around the world. VOA

Human testing expected soon

Antisense oligneucleotide targets the genetic instructions for building tau. The molecule binds to messenger RNA, which carries out the DNA blueprint for life, preventing tau from being produced. The drug can be made to target RNA for destruction of any protein, said scientists.

Tim Miller, a professor of neurology at Washington University and senior author of the study, hopes the drug, developed with Ionis Pharmaceuticals, will soon be tested in humans with Alzheimer’s disease.

“The most exciting and most interesting … is to apply this to people who we presume have abnormal tau to test the hypothesis whether lowering tau in those people will be of benefit to those people,” he said.

Check out NewsGram for latest international news updates.

Other types of antisense oligoneucleotides have been approved by U.S. regulators and are being used to treat the neurodegenerative disease muscular dystrophy and spinal muscular atrophy. The compound is in clinical trials for Huntington’s disease and ALS, also known as Lou Gehrig’s disease.

Because tau deposits are only a piece of the puzzle that causes Alzheimer’s, the investigators envision using the drug with other treatments, also in development.

There is no cure for Alzheimer’s disease, which primarily strikes senior adults, leading to a decline in mental functioning and eventually death. (VOA)

STAY CONNECTED

18,993FansLike
362FollowersFollow
1,782FollowersFollow

Most Popular

‘HotShots’, TikTok-like Short Video App by Ganna

Joining the short-video making app race, music streaming service Gaana on Wednesday launched HotShots - a platform to create and share short viral videos...

Foods that will Help Improve Your Sleep

There is a strong correlation between sleep quality and dietary patterns. High intake of confectionary and noodles was associated with poor sleep quality, whereas...

Here’s How Remdesivir Can Save Lives in Nations with Lower Hospital Capacity

Amid news that the US has bought up virtually the entire global supply of remdesivir, a new study outlines how the drug could save...

Instagram brings TikTok-like Feature to India

With the ban on TikTok creating a huge vacuum for the 15-second videos in the Indian Internet space, Facebook-owned Instagram on Wednesday announced the...

Smartphones not a Barrier to Parenting: Research

Parents may worry that spending time on their smartphones has a negative impact on their relationships with their children, however, a new study found...

Meditation Increases Immunity, says Research

Heartfulness meditation improves immunity against infections and cancer and is an effective adjunct in the treatment of several autoimmune disorders, a study said. In the...

Here Are Some Precautions to Take While Dining Out Amid Pandemic

There is some risk, but health officials say there are precautions you can take to minimize the chances you'll be exposed to the virus. Ordering...

High BP Medications May Also Reduce Colorectal Cancer Risk

Researchers have now claimed that medications commonly prescribed to treat high blood pressure may also reduce patients' colorectal cancer risk. Angiotensin converting enzyme inhibitor (ACE-i)...

Recent Comments